News

Fri 03 Mar 2023

Upcoming talk: in silico drug discovery and animal testing

Kantify will present at the upcoming study "Animals and Alternatives: The Way Forward"

Tue 28 Feb 2023

When AI meets Stem Cells: spotlight on our work with I-Stem

Kantify and I-Stem work together for faster rare disease drug discovery

Mon 06 Feb 2023

Special edition on Artificial Intelligence in La Libre Eco

Kantify in the special edition of La Libre Eco on Artificial Intelligence

Sun 05 Feb 2023

Kantify' CEO interview on TV LN24

Kantify's CEO was invited as "CEO of the week" by Bruno Wattenbergh on LN24

Thu 27 Oct 2022

Belgian AI Strategy: Kantify joins State Secretary

State Secretary Mathieu Michel invited us to illustrate the power of AI in Health at UCB for the launch event of the Belgian AI plan

Mon 17 Oct 2022

Kantify & Mcule harness data to accelerate drug discovery

Kantify, using its AI technology for drug discovery and Mcule,with its compound sourcing platform, are collaborating to leverage data for better hit prediction

Tue 09 Aug 2022

Kantify in BX1 show on startups and Artificial Intelligence

Kantify was invited to the special edition of BX-1's Startup Story on Start-Ups and Artificial Intelligence

Wed 20 Jul 2022

Fragile X Syndrome: Innovative Approaches to Finding a Cure

Join the talk of our CTO at this cornerstone online event of the Fragile-X patient and research communityt

Mon 30 May 2022

Targeted Protein Degradation : Kantify at Proteocure event

Kantify spoke about the latest progress of AI/ML for Degraders at the event of Proteocure

Mon 02 May 2022

Register to our webinar : Targeted Protein Degraders and AI

Discover how Artificial Intelligence can be used in the discovery and design of Targeted Protein Degraders.

Wed 27 Apr 2022

New discovery with I-Stem (Press Release)

Announcement : Kantify And I-Stem use Artificial Intelligence (AI) and Stem Cells to Discover A Promising Therapy Against A Rare Disease

Tue 19 Apr 2022

Pediatric acute lymphoblastic leukemia: New collaboration

In partnership with the Lyon University Hospital, Kantify is launching a project using Artificial Intelligence to identify leukemia cells (ALL)